Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
Abstract Background Available evidence suggests that adjunctive treatment with immunomodulatory medications may be effective in the treatment of major depressive disorder (MDD). A pilot trial of the tetracycline minocycline as adjunctive treatment in treatment-resistant depression (TRD), produced pr...
Main Authors: | Muhammad Ishrat Husain, Clare Cullen, Madeha Umer, Andre F. Carvalho, Stefan Kloiber, Jeffrey H. Meyer, Abigail Ortiz, Yuliya Knyahnytska, M. Omair Husain, Justine Giddens, Breno S. Diniz, Wei Wang, Allan H. Young, Benoit H. Mulsant, Zafiris J. Daskalakis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12888-020-02553-9 |
Similar Items
-
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
by: Husain MI, et al.
Published: (2016-12-01) -
Minocycline as adjunct therapy for a male patient with deficit schizophrenia
by: Chen X, et al.
Published: (2018-10-01) -
Comparison of efficacy of oral azithromycin with oral minocycline in the treatment of acne vulgaris
by: Vidyadhar R Sardesai, et al.
Published: (2017-01-01) -
Pigmentary and Other Dermatologic Manifestations of Minocycline: a reminder of adverse effects
by: Kayla Rodriguez, et al.
Published: (2019-10-01) -
Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future
by: Arezoo Asadi, et al.
Published: (2020-09-01)